ZYN57939
CAS No. 1639357-93-9
ZYN57939( MTR-106 )
Catalog No. M23736 CAS No. 1639357-93-9
ZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I- mediated diseases. ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT- 29 cancer cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 256 | In Stock |
|
| 5MG | 202 | In Stock |
|
| 10MG | 306 | In Stock |
|
| 25MG | 519 | In Stock |
|
| 50MG | 662 | In Stock |
|
| 100MG | 886 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZYN57939
-
NoteResearch use only, not for human use.
-
Brief DescriptionZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I- mediated diseases. ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT- 29 cancer cell lines.
-
DescriptionZYN57939 is RNA polymerase I inhibitor for treating RNA polymerase I- mediated diseases. ZYN57939 showed inhibitory activity with IC50 of 0.855 μM against human HT- 29 cancer cell lines.
-
In VitroCell Viability Assay Cell Line:HR-deficient and PARPi-resistant cancer cells Concentration:0-100 μM Incubation Time:7 days Result:Inhibited the viability of HR-deficient cells and PARPi-resistant cells in a dose-dependent nanner.Cell Cycle Analysis Cell Line:Capan-1 cells Concentration:0.1, 0.3, and 1 μM Incubation Time:24 hours Result:Increased in cells in G2/M, accompanied by a reduction in cell numbers in G1.Western Blot Analysis Cell Line:Capan-1 cells Concentration:1, 5, and 10 μM Incubation Time:24 hours Result:Increased the cleaved caspases 3, 7, and 9 and cleaved PARP in a dose-dependent manner.
-
In VivoAnimal Model:BRCA-deficient and PARPi-resistant xenografts in nude mice Dosage:10, 20, and 30 mg/kg Administration:oral administration; twice a week, for 29 days Result:Inhibited tumor growth in a dose-dependent manner.
-
SynonymsMTR-106
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorRNA polymerase I
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1639357-93-9
-
Formula Weight524.62
-
Molecular FormulaC29H28N6O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:Insoluble;Water:Insoluble
-
SMILESO=C1C(C(NCC2=NC=C(N=C2)C)=O)=C(SC3=CC=CC=C34)N4C5=NC(C6C[C@@](CN(C)C7)([H])[C@@]7([H])C6)=CC=C15
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers[J]. Investigational New Drugs, 2021:1-9.
molnova catalog
related products
-
Mechlorethamine hydr...
Mechlorethamine hydrochloride is a vesicant and necrotizing irritant destructive to mucous membranes.
-
NSAH?
NSAH is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.A unique nonnucleoside small-molecule hRR inhibitor, naphthyl salicylic acyl hydrazone (NSAH), using virtual screening, binding affinity, inhibition, and cell toxicity assays.?NSAH binds to hRRM1 with an apparent dissociation constant of 37 μM, and steady-state kinetics reveal a competitive mode of inhibition.?
-
Helicid
Helicid is a medicine available in a number of countries worldwide.
Cart
sales@molnova.com